Quantcast

Latest Heart failure Stories

2014-05-09 16:24:25

At Heart Rhythm 2014, panel of experts from three prominent medical groups share recommendations for patient populations not well represented in current guidelines SAN FRANCISCO, May 9, 2014 /PRNewswire/ -- The Heart Rhythm Society (HRS), American College of Cardiology (ACC) and American Heart Association (AHA) released Expert Consensus Statement on the Use of Implantable Cardioverter Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials...

2014-05-09 08:26:52

FRAMINGHAM, Mass., May 9, 2014 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Bank of America Merrill Lynch 2014 Health Care Conference at 12:00 p.m. PDT (3:00 p.m. EDT) on Tuesday, May 13, 2014. The conference is being held May 12-15 at the Encore at...

2014-05-08 08:34:00

In Reddit's 'Ask Me Anything' Section, Randy Shepherd Responds to Hundreds of Questions about His 10-Plus Months with the SynCardia Total Artificial Heart & His Completion of the 4.2-Mile Pat's Run on April 26, 2014 TUCSON, Ariz., May 8, 2014 /PRNewswire/ -- Randy Shepherd's fascinating story of life with a SynCardia temporary Total Artificial Heart has touched the hearts of many who have found inspiration as well as information on how the world's first and only FDA, Health Canada...

2014-05-06 08:36:03

CLEVELAND, May 6, 2014 /PRNewswire-USNewswire/ -- Juventas Therapeutics today announced that top-line interim data from its ongoing Phase II STOP-HF study will be presented in a late-breaking oral presentation at the European Society of Cardiology Heart Failure Congress (ESC-HF) taking place May 17 - 20, 2014 in Athens, Greece. The STOP-HF trial is a randomized, placebo-controlled, double-blinded study conducted at 15 centers in the United States to evaluate safety and efficacy of...

2014-05-05 08:29:16

Six-month Outcomes of AUGMENT-HF Multicenter Study to Be Presented by Yearend LAGUNA HILLS, Calif., May 5, 2014 /PRNewswire/ -- LoneStar Heart, Inc. today announced that it completed the patient recruitment phase of the company's AUGMENT-HF controlled randomized trial of Algisyl-LVR hydrogel implant, its lead product for the treatment of advanced heart failure (HF). LoneStar Heart expects to present six-month outcomes by yearend. The AUGMENT-HF clinical trial is being conducted at...

2014-05-05 08:28:17

SAN DIEGO, May 5, 2014 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX) today reported financial results for the quarter ended March 31, 2014. During the period, the Company made progress across multiple clinical and corporate fronts, including the ex?U.S. expansion of EPIC, it's pivotal Phase 3 study of MST-188 in sickle cell disease, and pipeline expansion with the acquisition of AIR001, a clinical-stage program. Other highlights included initiating a Phase 2 study of...

2014-04-30 11:51:15

Found to be 'safe and well tolerated' in randomized clinical trial A drug known to reduce mortality rate in patients with heart failure has now been found significantly effective when administered early in patients following an acute (ST elevated) myocardial infarction. This effect,say the investigators, was consistent across all study sub-groups, but was "particularly obvious in patients undergoing reperfusion within six hours of symptom onset". Eplerenone, a mineralocorticoid receptor...

2014-04-29 23:11:01

UVA technique tailors pacemaker-defibrillator installation for best outcomes. Charlottesville, VA (PRWEB) April 29, 2014 Important new research from the University of Virginia Health System explains why patients with heart failure do or do not respond to a very effective form of treatment, cardiac resynchronization therapy (CRT). The research successfully identified which patients would benefit and enables doctors to create an unprecedented map of a patient’s heart to guide the...

2014-04-29 20:23:32

LONDON, April 29, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:The World Market for Cardiovascular Diagnosticshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/world_market_cardiovascular_diagnostics_1.htmlThis report provides the reader with an overview of the global cardiac diagnostics industry and the trends driving growth. Segments within the cardiac diagnostic market include:-- Electrocardiography including ECG testing, stress testing, Holter...

2014-04-29 12:29:21

Randy Shepherd, Kept Alive for 10 Months by the SynCardia Total Artificial Heart Powered by the Freedom Portable Driver, Walked the April 26, 2014 Long-Distance Course Honoring Pat Tillman TUCSON, Ariz., April 29, 2014 /PRNewswire/ -- Randy Shepherd's 4.2-mile walk in Pat's Run April 26, 2014, in the Phoenix area was more than a test of his endurance. It was part of his training for the most crucial event of his life--a heart transplant....


Latest Heart failure Reference Libraries

Circulation (journal)
2012-06-04 14:21:01

Circulation is a scientific journal published by Lippincott Williams & Wilkins on behalf of the American Heart Association. In 2008 the journal added six subspecialty publications: Circulation: Arrhythmia and Electrophysiology, Circulation: Heart Failure, Circulation: Cardiovascular Imaging, Circulation: Cardiovascular Interventions, Circulation: Cardiovascular Quality and Outcomes, and Circulation: Cardiovascular Genetics. Circulation publishes articles related to research in and the...

More Articles (1 articles) »
Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related